SLG
ADAP

Stanley-Laman Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Stanley-Laman Group’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-565,271
Closed -$7.67M – 250
2018
Q3 		$7.67M Buy
+565,271
New +$7.67M 1.88% 5